| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |